A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Public ClinicalTrials.gov record NCT04419649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main aim of this study is to learn how safe elritercept is and how well adults with anemia associated with lower-risk MDS tolerate treatment with different doses of elritercept. Other aims are to learn how safe elritercept is by looking at how many participants have MDS that worsens during the study and learn about the effects of elritercept on anemia linked to MDS. The study will also look to learn how elritercept affects the production of healthy RBCs.
Study identification
- NCT ID
- NCT04419649
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 19, 2020 (Actual)
- Primary completion
- Oct 30, 2029 (Estimated)
- Completion
- Oct 30, 2031 (Estimated)
- Last update posted
- Aug 21, 2026
2020 – 2031
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Genesis Cancer and Blood Institute | Hot Springs | Arkansas | 71913 | Recruiting |
| City of Hope National Medical Center | Duarte | California | 91010 | Recruiting |
| University of Miami School of Medicine Sylvester Comprehensive Cancer Center (SCCC) | Miami | Florida | 33136 | Recruiting |
| H. Lee Moffitt Cancer Center and Research Center | Tampa | Florida | 33612 | Recruiting |
| The Center for Cancer and Blood Disorders (CCBD) - Bethesda | Bethesda | Maryland | 20817 | Recruiting |
| Karmanos Cancer Institute at Mclaren Greater Lansing | Lansing | Michigan | 48910 | Completed |
| Hackensack Medical Center | Hackensack | New Jersey | 07601 | Recruiting |
| New York Cancer and Blood | Shirley | New York | 11967 | Recruiting |
| University of Pittsburgh Medical Health Center | Pittsburgh | Pennsylvania | 15213 | Completed |
| Baptist Clinical Research Institute | Memphis | Tennessee | 38120 | Recruiting |
| Univ of Texas MD Anderson Cancer Center, Division of Cancer Medicine | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04419649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 21, 2026 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04419649 live on ClinicalTrials.gov.